NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Mizuho Turns Bearish on NXP: Auto Exposure and Weak 2026 Outlook Cited

Mizuho cut NXP to sell, slashing target to $188 on weak car demand and high inventory.

Mizuho Turns Bearish on NXP: Auto Exposure and Weak 2026 Outlook Cited
Credit: Jock Fistick/Bloomberg
Already have an account? Sign in.
04/17/2026 · 6:26 AM
NXPI
/ Don’t stop at just one post.

Related↓

NXP Semiconductors Beats Q4 Expectations, Forecasts Strong Q1 Revenue
02/03/2026 · 5:59 AM

NXP Semiconductors Beats Q4 Expectations, Forecasts Strong Q1 Revenue

NXP Semiconductors exceeds Q4 estimates and predicts Q1 revenue above expectations, driven by automotive and industrial demand, despite communication sector weakness.

/ Subscriber only
/ Read more

Feed↓

Kura Oncology Stock Surges as Darlifarib + Cabozantinib Shows Strong Results in Tough Kidney Cancer Cases
04/17/2026 · 7:14 AM

Kura Oncology Stock Surges as Darlifarib + Cabozantinib Shows Strong Results in Tough Kidney Cancer Cases

Kura Oncology’s combo drug shrank kidney tumors in early trial, controlled cancer in most patients, stock jumped.

/ Subscriber only
Morgan Stanley Names Affirm as Top Pick with 26% Upside
04/17/2026 · 6:52 AM

Morgan Stanley Names Affirm as Top Pick with 26% Upside

Affirm is viewed as a strong buy with solid growth, stable funding, and potential upside as positive updates are expected soon.

/ Subscriber only
Goldman Sachs Highlights Corvus Pharmaceuticals as a Promising Oral Player in $24 Billion Atopic Dermatitis Market
04/17/2026 · 6:11 AM

Goldman Sachs Highlights Corvus Pharmaceuticals as a Promising Oral Player in $24 Billion Atopic Dermatitis Market

Goldman sees Corvus as a buy: its oral eczema drug could rival Dupixent and grow into multiple diseases, boosting the stock potential.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe